Mitroaortic valve replacement after aortic transapical approach failure in a patient with essential thrombocytosis.
There is a lack of published information about intraoperative and postoperative course of cardiac surgery in patients with essential thrombocytosis using cardiopulmonary bypass. Both risks of intraoperative thrombosis of extracorporeal conduits or uncontrolled postoperative bleeding are present, but its incidence and treatment are not well known. Here, we present a rare case of a patient with essential thrombocytosis, moderate mitral regurgitation and severe aortic stenosis who had a transapical aortic valve implantation with short-term severe periprosthetic regurgitation, who needed a mitroaortic replacement on cardiopulmonary bypass with no complications.
Gutierrez-Martin
Maria A
MA
Department of Cardiovascular Surgery, Virgen Macarena University Hospital, Avenida Dr. Fedriani 3, 3 planta ala D., 41071 Sevilla, Spain. ma.gutierrez.martin@gmail.com
Araji
Omar A
OA
Miranda
Nuria
N
Barquero
Jose M
JM
D001024:Aortic Valve Stenosis / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging / Q000601:surgery / Q000628:therapy*; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000295:instrumentation*; D002315:Cardiopulmonary Bypass; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging / Q000601:surgery*; D011474:Prosthesis Design; D011475:Prosthesis Failure; D013922:Thrombocytosis / Q000097:blood / Q000150:complications*; D016896:Treatment Outcome; D014463:Ultrasonography